2006-10-11 Jong, F.A. de

A Roadmap to Individualized Irinotecan Dosing

Erasmus MC: University Medical Center Rotterdam

2006-06-08 Glabbeke, M.M.B. van

Advanced soft tissue sarcoma: prognostic factors and aspects of trial methodology

Erasmus MC: University Medical Center Rotterdam

2006-06-08 Therasse, P.A.J.P.

Response assessment in cancer clinical trials

Erasmus MC: University Medical Center Rotterdam

2004-09-23 Baker, S.D.

Factors Affecting Pharmacokinetic Variability of Docetaxel

Erasmus MC: University Medical Center Rotterdam

2003-10-29 Jongh, F.E. de

Cisplatin Scheduling and Dosing Aspects

Erasmus MC: University Medical Center Rotterdam

2002-11-06 Mathijssen, A.H.J.

Irinotecan: from clinical pharmacokinetics to pharmacogenetics

Erasmus MC: University Medical Center Rotterdam

2002-06-21 Smorenburg, C.H.

New treatment modalities and pharmacologic refinements for metatstatic breast cancer

Erasmus MC: University Medical Center Rotterdam

2001-11-16 Kehrer, D.F.S.

Pharmacologic Modulation of Topoisomerase I Inhibitors

Erasmus MC: University Medical Center Rotterdam

2001-09-14 Gelderblom, A.J.

Pharmacologic aspects of new classes of anti-cancer agents: inhibitors of topoisomerase I or tubulin

Erasmus MC: University Medical Center Rotterdam

2001-02-14 Eskens, F.A.L.M.

Early clinical studies exploring new targets in anticancer treatment

Erasmus MC: University Medical Center Rotterdam